Abstract

BackgroundIntrahepatic cholangiocarcinomas are malignant tumors arising from the intrahepatic biliary tract. The pathogenesis of these tumors remains unknown. Although there is a marked global variation in prevalence, some recent studies have suggested an increase in mortality from intrahepatic cholangiocarcinoma in several regions of low endemicity. As the study of mortality trends may yield clues to possible etiological factors, we analyzed worldwide time trends in mortality from biliary tract malignancies.MethodsAnnual age-standardized rates for individual countries were compiled for deaths from biliary tract malignancies using the WHO database. These data were used to analyze gender and site-specific trends in mortality rates.ResultsAn increasing trend for mortality from intrahepatic cholangiocarcinoma was noted in most countries. The average estimated annual percentage change (EAPC) in mortality rates for males was 6.9 ± 1.5, and for females was 5.1 ± 1.0. Increased mortality rates were observed in all geographic regions. Within Europe, increases were higher in Western Europe than in Central or Northern Europe. In contrast, mortality rates for extrahepatic biliary tract malignancies showed a decreasing trend in most countries, with an overall average EAPC of -0.3 ± 0.4 for males, but -1.3 ± 0.4 for females.ConclusionsThere has been a marked global increase in mortality from intrahepatic, but not extra-hepatic, biliary tract malignancies.

Highlights

  • Intrahepatic cholangiocarcinomas are malignant tumors arising from the intrahepatic biliary tract

  • Tumors can arise from intrahepatic bile ducts, extrahepatic bile ducts, or the gall bladder

  • Intrahepatic cholangiocarcinomas are highly prevalent in certain regions such as Thailand and Southeast Asia [2]

Read more

Summary

Introduction

Intrahepatic cholangiocarcinomas are malignant tumors arising from the intrahepatic biliary tract. The pathogenesis of these tumors remains unknown. Biliary tract tumors have proven challenging to treat and manage due to their poor sensitivity to conventional therapies and our inability to prevent or to detect early tumor formation [1]. Tumors can arise from intrahepatic bile ducts (intrahepatic cholangiocarcinoma), extrahepatic bile ducts, or the gall bladder. The precise etiology and pathogenesis of these tumors remain obscure [5]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.